+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Metabolomics Reagents Market - Global Forecast 2026-2032- Product Image
Metabolomics Reagents Market - Global Forecast 2026-2032- Product Image
Sale

Metabolomics Reagents Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6127843
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Metabolomics Reagents Market is projected to reach USD 1.91 Billion in 2026. It is expected to continue growing at a CAGR of 7.23%, reaching USD 2.93 Billion by 2032.

Metabolomics Reagents: Executive Summary

Metabolomics reagents support the extraction, preparation, separation, identification, and quantification of metabolites in biological and environmental samples. Demand is shaped by growth in biomarker discovery, translational research, pharmaceutical development, food analysis, and precision-medicine workflows. The market is technically diverse, spanning standards, solvents, derivatization chemicals, extraction materials, enzyme substrates, analytical controls, and workflow-specific consumables.

Workflow Integration Is Reshaping Metabolomics Reagent Demand

The landscape is shifting from isolated reagent purchases toward integrated, reproducible workflows. Laboratories increasingly prioritize lot consistency, traceability, compatibility with mass spectrometry and nuclear magnetic resonance platforms, validated sample-preparation protocols, and dependable cold-chain or controlled-storage performance. Greater use of targeted and untargeted methods is also expanding the need for high-purity standards, reference materials, internal standards, and quality-control materials. Regulatory expectations around data integrity and method validation are reinforcing demand for documented specifications and standardized operating procedures.

Artificial Intelligence Is Accelerating Interpretation and Quality Control

Artificial intelligence is influencing metabolomics primarily through data processing rather than reagent manufacture. Machine-learning tools can assist with peak detection, feature alignment, compound annotation, pathway analysis, anomaly detection, and selection of informative biomarkers. These applications increase the value of consistent reagent composition, stable internal standards, and well-characterized controls because model performance depends on comparable data generated across batches and laboratories. Adoption remains dependent on transparent algorithms, interoperable data formats, adequate reference libraries, and human review of chemically ambiguous assignments.

Regional Patterns Reflect Research Capacity and Laboratory Infrastructure

North America combines strong pharmaceutical, academic, and clinical-research activity with established analytical infrastructure. Europe benefits from collaborative research networks, stringent quality expectations, and coordinated scientific programs, while Asia-Pacific is supported by expanding biotechnology capacity, growing pharmaceutical research, and increasing investment in advanced analytical platforms. Latin America is developing through academic, agricultural, nutritional, and clinical applications, though procurement complexity and access to specialized instrumentation can affect adoption. The Middle East is building research capability through institutional investment and healthcare modernization, whereas Africa presents opportunities in infectious disease, nutrition, agriculture, and public-health research alongside infrastructure and training constraints.

Economic and Institutional Groups Create Distinct Adoption Conditions

ASEAN markets are expanding scientific collaboration and laboratory capabilities, with demand influenced by food, agriculture, health, and biotechnology applications. BRICS members combine large and diverse research systems but differ substantially in infrastructure, regulatory conditions, and domestic manufacturing capacity. The European Union emphasizes harmonization, quality documentation, and cross-border research interoperability. G7 countries generally provide mature pharmaceutical, clinical, and academic ecosystems with high expectations for reproducibility. GCC members are strengthening biomedical and life-science infrastructure, while NATO countries collectively include extensive defense, public-health, and research networks that can support advanced analytical applications.

Country-Level Priorities Span Discovery, Healthcare, and Local Capability

Australia supports metabolomics through medical, agricultural, environmental, and university research. Brazil applies the discipline across agriculture, biodiversity, nutrition, and health, while Canada emphasizes translational research, food science, and natural-resource applications. China is expanding domestic analytical and biotechnology capacity; India is advancing pharmaceutical, clinical, agricultural, and academic use cases. Japan and South Korea maintain sophisticated technology ecosystems, with strong emphasis on precision measurement and industrial research. In Europe, France, Germany, Italy, Spain, and the United Kingdom combine established research institutions with pharmaceutical, food, environmental, and clinical applications. Mexico is developing capabilities across health, agriculture, and industrial research. Russia retains scientific expertise across biomedical and environmental fields, although access to equipment, imported materials, and international collaboration can vary. The United States remains a major center for pharmaceutical, clinical, academic, and analytical innovation.

Prioritize Reproducibility, Application Fit, and Regional Resilience

Industry leaders should segment reagent portfolios by workflow, analyte class, instrument compatibility, and application rather than treating metabolomics as a single use case. Product documentation should clearly specify purity, contaminant limits, storage conditions, lot traceability, and validation evidence. Building dual-source or regionally diversified supply arrangements can reduce disruption risk for critical solvents, standards, and controls. Partnerships with laboratories and instrument users can improve protocol compatibility, while digital certificates, barcoding, and batch-level quality data can strengthen confidence. Providers should also prepare for AI-enabled workflows by supporting standardized metadata, reference libraries, and quality-control schemes that make datasets comparable.

Methodology: Triangulating Scientific, Commercial, and Regulatory Evidence

This executive summary uses a structured secondary-research approach focused on metabolomics reagent applications, workflow requirements, laboratory infrastructure, and regional adoption conditions. Evidence should be triangulated across peer-reviewed literature, regulatory and standards publications, institutional research programs, technical documentation, procurement records where available, and public information on biotechnology and analytical-laboratory activity. Findings are organized by workflow, geography, economic grouping, and country, with qualitative comparison used to identify drivers, constraints, and operational priorities. Claims are limited to observable industry developments and do not include market estimates, market sizing, market shares, or forecasts.

Reproducibility and Workflow Integration Will Define Competitive Advantage

Metabolomics reagent demand is increasingly connected to the reliability of complete analytical workflows. Growth in biomedical, pharmaceutical, food, agricultural, and environmental applications is raising expectations for purity, consistency, documentation, and application support. Regional and country conditions remain uneven, making localization, resilient supply, and technical partnerships important. Organizations that combine dependable reagents with strong quality systems, interoperable data practices, and AI-ready workflow support will be better positioned to serve laboratories seeking reproducible and actionable metabolomics results.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Metabolomics Reagents Market, by Technology
7.1. Introduction
7.2. GC-MS
7.2.1. Single Quadrupole
7.2.2. Triple Quadrupole
7.3. LC-MS
7.3.1. Q-Orbitrap
7.3.2. Q-TOF
7.3.3. Triple Quadrupole
7.4. NMR
7.4.1. 13C-NMR
7.4.2. 1H-NMR
8. Metabolomics Reagents Market, by Product Type
8.1. Introduction
8.2. Chromatography Columns
8.2.1. HILIC Columns
8.2.2. Reversed Phase Columns
8.3. Derivatization Reagents
8.3.1. Alkylation Agents
8.3.2. Silylation Agents
8.4. Ionization Reagents
8.4.1. APCI Reagents
8.4.2. ESI Reagents
8.5. Solvents
8.5.1. Acetonitrile
8.5.2. Methanol
8.5.3. Water
9. Metabolomics Reagents Market, by Sample Type
9.1. Introduction
9.2. Serum
9.3. Tissue
9.3.1. Kidney
9.3.2. Liver
9.4. Urine
10. Metabolomics Reagents Market, by Application
10.1. Introduction
10.2. Agriculture Food Safety
10.2.1. Mycotoxin Detection
10.2.2. Pesticide Residues
10.3. Biomarker Discovery
10.3.1. Disease Biomarkers
10.3.2. Metabolic Biomarkers
10.4. Clinical Diagnostics
10.4.1. Cancer Diagnostics
10.4.2. Metabolic Disorder Diagnostics
10.5. Drug Development
10.5.1. Pharmacokinetics
10.5.2. Toxicology Studies
11. Metabolomics Reagents Market, by End User
11.1. Introduction
11.2. Academic And Research Institutes
11.3. Biotechnology Firms
11.4. Contract Research Organizations
11.5. Pharmaceutical Companies
12. Metabolomics Reagents Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Metabolomics Reagents Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Metabolomics Reagents Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Agilent Technologies, Inc.
16.2. Bio-Rad Laboratories, Inc.
16.3. Biocrates Life Sciences AG
16.4. Bruker Corporation
16.5. Danaher Corporation
16.6. Merck KGaA
16.7. PerkinElmer, Inc.
16.8. QIAGEN N.V.
16.9. Shimadzu Corporation
16.10. Thermo Fisher Scientific Inc.
16.11. Waters Corporation
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Metabolomics Reagents Market, Years Considered for the Study
FIGURE 2. Global Metabolomics Reagents Market, Research Design
FIGURE 3. Global Metabolomics Reagents Market, Research Framework
FIGURE 4. Global Metabolomics Reagents Market, Data Triangulation
FIGURE 5. Global Metabolomics Reagents Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Metabolomics Reagents Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Metabolomics Reagents Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Metabolomics Reagents Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Metabolomics Reagents Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Metabolomics Reagents Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Metabolomics Reagents Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Metabolomics Reagents Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Metabolomics Reagents Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Metabolomics Reagents Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Metabolomics Reagents Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Metabolomics Reagents Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Metabolomics Reagents Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Metabolomics Reagents Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Metabolomics Reagents Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Metabolomics Reagents Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Metabolomics Reagents Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Metabolomics Reagents Market Segmentation & Coverage
TABLE 2. Global Metabolomics Reagents Market Size, 2017-2032 (USD Million)
TABLE 3. Global Metabolomics Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global GC-MS Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global GC-MS Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global GC-MS Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Single Quadrupole Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Single Quadrupole Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Single Quadrupole Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Triple Quadrupole Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Triple Quadrupole Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Triple Quadrupole Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global LC-MS Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global LC-MS Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global LC-MS Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Q-Orbitrap Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Q-Orbitrap Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Q-Orbitrap Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Q-TOF Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Q-TOF Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Q-TOF Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Triple Quadrupole Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Triple Quadrupole Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Triple Quadrupole Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global NMR Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global NMR Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global NMR Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global 13C-NMR Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global 13C-NMR Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global 13C-NMR Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global 1H-NMR Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global 1H-NMR Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global 1H-NMR Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Metabolomics Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 35. Global Chromatography Columns Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Chromatography Columns Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Chromatography Columns Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global HILIC Columns Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global HILIC Columns Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global HILIC Columns Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Reversed Phase Columns Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Reversed Phase Columns Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Reversed Phase Columns Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Derivatization Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Derivatization Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Derivatization Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Alkylation Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Alkylation Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Alkylation Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Silylation Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Silylation Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Silylation Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Ionization Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Ionization Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Ionization Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global APCI Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global APCI Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global APCI Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global ESI Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global ESI Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global ESI Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Solvents Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Solvents Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Solvents Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Acetonitrile Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Acetonitrile Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Acetonitrile Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Methanol Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Methanol Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Methanol Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Water Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Water Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Water Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Metabolomics Reagents Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 75. Global Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Tissue Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Tissue Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Tissue Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Kidney Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Kidney Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Kidney Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Liver Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Liver Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Liver Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Metabolomics Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 91. Global Agriculture Food Safety Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Agriculture Food Safety Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Agriculture Food Safety Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Mycotoxin Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Mycotoxin Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Mycotoxin Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Pesticide Residues Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Pesticide Residues Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Pesticide Residues Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Biomarker Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Biomarker Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Biomarker Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Disease Biomarkers Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Disease Biomarkers Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Disease Biomarkers Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Metabolic Biomarkers Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Metabolic Biomarkers Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Metabolic Biomarkers Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Clinical Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Clinical Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Clinical Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Cancer Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Cancer Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Cancer Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Metabolic Disorder Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Metabolic Disorder Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Metabolic Disorder Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Drug Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Drug Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Drug Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Pharmacokinetics Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Pharmacokinetics Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Pharmacokinetics Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Toxicology Studies Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Toxicology Studies Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Toxicology Studies Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Metabolomics Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. Global Academic And Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Academic And Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Academic And Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Biotechnology Firms Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Biotechnology Firms Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Biotechnology Firms Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. Global Metabolomics Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Asia-Pacific Metabolomics Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Asia-Pacific Metabolomics Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 143. Asia-Pacific Metabolomics Reagents Market Size, by GC-MS, 2017-2032 (USD Million)
TABLE 144. Asia-Pacific Metabolomics Reagents Market Size, by LC-MS, 2017-2032 (USD Million)
TABLE 145. Asia-Pacific Metabolomics Reagents Market Size, by NMR, 2017-2032 (USD Million)
TABLE 146. Asia-Pacific Metabolomics Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 147. Asia-Pacific Metabolomics Reagents Market Size, by Chromatography Columns, 2017-2032 (USD Million)
TABLE 148. Asia-Pacific Metabolomics Reagents Market Size, by Derivatization Reagents, 2017-2032 (USD Million)
TABLE 149. Asia-Pacific Metabolomics Reagents Market Size, by Ionization Reagents, 2017-2032 (USD Million)
TABLE 150. Asia-Pacific Metabolomics Reagents Market Size, by Solvents, 2017-2032 (USD Million)
TABLE 151. Asia-Pacific Metabolomics Reagents Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 152. Asia-Pacific Metabolomics Reagents Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 153. Asia-Pacific Metabolomics Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 154. Asia-Pacific Metabolomics Reagents Market Size, by Agriculture Food Safety, 2017-2032 (USD Million)
TABLE 155. Asia-Pacific Metabolomics Reagents Market Size, by Biomarker Discovery, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific Metabolomics Reagents Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific Metabolomics Reagents Market Size, by Drug Development, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific Metabolomics Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. North America Metabolomics Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. North America Metabolomics Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 161. North America Metabolomics Reagents Market Size, by GC-MS, 2017-2032 (USD Million)
TABLE 162. North America Metabolomics Reagents Market Size, by LC-MS, 2017-2032 (USD Million)
TABLE 163. North America Metabolomics Reagents Market Size, by NMR, 2017-2032 (USD Million)
TABLE 164. North America Metabolomics Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 165. North America Metabolomics Reagents Market Size, by Chromatography Columns, 2017-2032 (USD Million)
TABLE 166. North America Metabolomics Reagents Market Size, by Derivatization Reagents, 2017-2032 (USD Million)
TABLE 167. North America Metabolomics Reagents Market Size, by Ionization Reagents, 2017-2032 (USD Million)
TABLE 168. North America Metabolomics Reagents Market Size, by Solvents, 2017-2032 (USD Million)
TABLE 169. North America Metabolomics Reagents Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 170. North America Metabolomics Reagents Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 171. North America Metabolomics Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 172. North America Metabolomics Reagents Market Size, by Agriculture Food Safety, 2017-2032 (USD Million)
TABLE 173. North America Metabolomics Reagents Market Size, by Biomarker Discovery, 2017-2032 (USD Million)
TABLE 174. North America Metabolomics Reagents Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 175. North America Metabolomics Reagents Market Size, by Drug Development, 2017-2032 (USD Million)
TABLE 176. North America Metabolomics Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. Latin America Metabolomics Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 178. Latin America Metabolomics Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 179. Latin America Metabolomics Reagents Market Size, by GC-MS, 2017-2032 (USD Million)
TABLE 180. Latin America Metabolomics Reagents Market Size, by LC-MS, 2017-2032 (USD Million)
TABLE 181. Latin America Metabolomics Reagents Market Size, by NMR, 2017-2032 (USD Million)
TABLE 182. Latin America Metabolomics Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 183. Latin America Metabolomics Reagents Market Size, by Chromatography Columns, 2017-2032 (USD Million)
TABLE 184. Latin America Metabolomics Reagents Market Size, by Derivatization Reagents, 2017-2032 (USD Million)
TABLE 185. Latin America Metabolomics Reagents Market Size, by Ionization Reagents, 2017-2032 (USD Million)
TABLE 186. Latin America Metabolomics Reagents Market Size, by Solvents, 2017-2032 (USD Million)
TABLE 187. Latin America Metabolomics Reagents Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 188. Latin America Metabolomics Reagents Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 189. Latin America Metabolomics Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. Latin America Metabolomics Reagents Market Size, by Agriculture Food Safety, 2017-2032 (USD Million)
TABLE 191. Latin America Metabolomics Reagents Market Size, by Biomarker Discovery, 2017-2032 (USD Million)
TABLE 192. Latin America Metabolomics Reagents Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 193. Latin America Metabolomics Reagents Market Size, by Drug Development, 2017-2032 (USD Million)
TABLE 194. Latin America Metabolomics Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. Europe Metabolomics Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 196. Europe Metabolomics Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 197. Europe Metabolomics Reagents Market Size, by GC-MS, 2017-2032 (USD Million)
TABLE 198. Europe Metabolomics Reagents Market Size, by LC-MS, 2017-2032 (USD Million)
TABLE 199. Europe Metabolomics Reagents Market Size, by NMR, 2017-2032 (USD Million)
TABLE 200. Europe Metabolomics Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 201. Europe Metabolomics Reagents Market Size, by Chromatography Columns, 2017-2032 (USD Million)
TABLE 202. Europe Metabolomics Reagents Market Size, by Derivatization Reagents, 2017-2032 (USD Million)
TABLE 203. Europe Metabolomics Reagents Market Size, by Ionization Reagents, 2017-2032 (USD Million)
TABLE 204. Europe Metabolomics Reagents Market Size, by Solvents, 2017-2032 (USD Million)
TABLE 205. Europe Metabolomics Reagents Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 206. Europe Metabolomics Reagents Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 207. Europe Metabolomics Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. Europe Metabolomics Reagents Market Size, by Agriculture Food Safety, 2017-2032 (USD Million)
TABLE 209. Europe Metabolomics Reagents Market Size, by Biomarker Discovery, 2017-2032 (USD Million)
TABLE 210. Europe Metabolomics Reagents Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 211. Europe Metabolomics Reagents Market Size, by Drug Development, 2017-2032 (USD Million)
TABLE 212. Europe Metabolomics Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. Middle East Metabolomics Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 214. Middle East Metabolomics Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 215. Middle East Metabolomics Reagents Market Size, by GC-MS, 2017-2032 (USD Million)
TABLE 216. Middle East Metabolomics Reagents Market Size, by LC-MS, 2017-2032 (USD Million)
TABLE 217. Middle East Metabolomics Reagents Market Size, by NMR, 2017-2032 (USD Million)
TABLE 218. Middle East Metabolomics Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 219. Middle East Metabolomics Reagents Market Size, by Chromatography Columns, 2017-2032 (USD Million)
TABLE 220. Middle East Metabolomics Reagents Market Size, by Derivatization Reagents, 2017-2032 (USD Million)
TABLE 221. Middle East Metabolomics Reagents Market Size, by Ionization Reagents, 2017-2032 (USD Million)
TABLE 222. Middle East Metabolomics Reagents Market Size, by Solvents, 2017-2032 (USD Million)
TABLE 223. Middle East Metabolomics Reagents Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 224. Middle East Metabolomics Reagents Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 225. Middle East Metabolomics Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. Middle East Metabolomics Reagents Market Size, by Agriculture Food Safety, 2017-2032 (USD Million)
TABLE 227. Middle East Metabolomics Reagents Market Size, by Biomarker Discovery, 2017-2032 (USD Million)
TABLE 228. Middle East Metabolomics Reagents Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 229. Middle East Metabolomics Reagents Market Size, by Drug Development, 2017-2032 (USD Million)
TABLE 230. Middle East Metabolomics Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. Africa Metabolomics Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 232. Africa Metabolomics Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 233. Africa Metabolomics Reagents Market Size, by GC-MS, 2017-2032 (USD Million)
TABLE 234. Africa Metabolomics Reagents Market Size, by LC-MS, 2017-2032 (USD Million)
TABLE 235. Africa Metabolomics Reagents Market Size, by NMR, 2017-2032 (USD Million)
TABLE 236. Africa Metabolomics Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 237. Africa Metabolomics Reagents Market Size, by Chromatography Columns, 2017-2032 (USD Million)
TABLE 238. Africa Metabolomics Reagents Market Size, by Derivatization Reagents, 2017-2032 (USD Million)
TABLE 239. Africa Metabolomics Reagents Market Size, by Ionization Reagents, 2017-2032 (USD Million)
TABLE 240. Africa Metabolomics Reagents Market Size, by Solvents, 2017-2032 (USD Million)
TABLE 241. Africa Metabolomics Reagents Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 242. Africa Metabolomics Reagents Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 243. Africa Metabolomics Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 244. Africa Metabolomics Reagents Market Size, by Agriculture Food Safety, 2017-2032 (USD Million)
TABLE 245. Africa Metabolomics Reagents Market Size, by Biomarker Discovery, 2017-2032 (USD Million)
TABLE 246. Africa Metabolomics Reagents Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 247. Africa Metabolomics Reagents Market Size, by Drug Development, 2017-2032 (USD Million)
TABLE 248. Africa Metabolomics Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. Global Metabolomics Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 250. ASEAN Metabolomics Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 251. ASEAN Metabolomics Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 252. ASEAN Metabolomics Reagents Market Size, by GC-MS, 2017-2032 (USD Million)
TABLE 253. ASEAN Metabolomics Reagents Market Size, by LC-MS, 2017-2032 (USD Million)
TABLE 254. ASEAN Metabolomics Reagents Market Size, by NMR, 2017-2032 (USD Million)
TABLE 255. ASEAN Metabolomics Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 256. ASEAN Metabolomics Reagents Market Size, by Chromatography Columns, 2017-2032 (USD Million)
TABLE 257. ASEAN Metabolomics Reagents Market Size, by Derivatization Reagents, 2017-2032 (USD Million)
TABLE 258. ASEAN Metabolomics Reagents Market Size, by Ionization Reagents, 2017-2032 (USD Million)
TABLE 259. ASEAN Metabolomics Reagents Market Size, by Solvents, 2017-2032 (USD Million)
TABLE 260. ASEAN Metabolomics Reagents Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 261. ASEAN Metabolomics Reagents Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 262. ASEAN Metabolomics Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 263. ASEAN Metabolomics Reagents Market Size, by Agriculture Food Safety, 2017-2032 (USD Million)
TABLE 264. ASEAN Metabolomics Reagents Market Size, by Biomarker Discovery, 2017-2032 (USD Million)
TABLE 265. ASEAN Metabolomics Reagents Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 266. ASEAN Metabolomics Reagents Market Size, by Drug Development, 2017-2032 (USD Million)
TABLE 267. ASEAN Metabolomics Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 268. GCC Metabolomics Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 269. GCC Metabolomics Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 270. GCC Metabolomics Reagents Market Size, by GC-MS, 2017-2032 (USD Million)
TABLE 271. GCC Metabolomics Reagents Market Size, by LC-MS, 2017-2032 (USD Million)
TABLE 272. GCC Metabolomics Reagents Market Size, by NMR, 2017-2032 (USD Million)
TABLE 273. GCC Metabolomics Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 274. GCC Metabolomics Reagents Market Size, by Chromatography Columns, 2017-2032 (USD Million)
TABLE 275. GCC Metabolomics Reagents Market Size, by Derivatization Reagents, 2017-2032 (USD Million)
TABLE 276. GCC Metabolomics Reagents Market Size, by Ionization Reagents, 2017-2032 (USD Million)
TABLE 277. GCC Metabolomics Reagents Market Size, by Solvents, 2017-2032 (USD Million)
TABLE 278. GCC Metabolomics Reagents Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 279. GCC Metabolomics Reagents Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 280. GCC Metabolomics Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 281. GCC Metabolomics Reagents Market Size, by Agriculture Food Safety, 2017-2032 (USD Million)
TABLE 282. GCC Metabolomics Reagents Market Size, by Biomarker Discovery, 2017-2032 (USD Million)
TABLE 283. GCC Metabolomics Reagents Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 284. GCC Metabolomics Reagents Market Size, by Drug Development, 2017-2032 (USD Million)
TABLE 285. GCC Metabolomics Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. European Union Metabolomics Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 287. European Union Metabolomics Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 288. European Union Metabolomics Reagents Market Size, by GC-MS, 2017-2032 (USD Million)
TABLE 289. European Union Metabolomics Reagents Market Size, by LC-MS, 2017-2032 (USD Million)
TABLE 290. European Union Metabolomics Reagents Market Size, by NMR, 2017-2032 (USD Million)
TABLE 291. European Union Metabolomics Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 292. European Union Metabolomics Reagents Market Size, by Chromatography Columns, 2017-2032 (USD Million)
TABLE 293. European Union Metabolomics Reagents Market Size, by Derivatization Reagents, 2017-2032 (USD Million)
TABLE 294. European Union Metabolomics Reagents Market Size, by Ionization Reagents, 2017-2032 (USD Million)
TABLE 295. European Union Metabolomics Reagents Market Size, by Solvents, 2017-2032 (USD Million)
TABLE 296. European Union Metabolomics Reagents Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 297. European Union Metabolomics Reagents Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 298. European Union Metabolomics Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 299. European Union Metabolomics Reagents Market Size, by Agriculture Food Safety, 2017-2032 (USD Million)
TABLE 300. European Union Metabolomics Reagents Market Size, by Biomarker Discovery, 2017-2032 (USD Million)
TABLE 301. European Union Metabolomics Reagents Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 302. European Union Metabolomics Reagents Market Size, by Drug Development, 2017-2032 (USD Million)
TABLE 303. European Union Metabolomics Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 304. BRICS Metabolomics Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 305. BRICS Metabolomics Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 306. BRICS Metabolomics Reagents Market Size, by GC-MS, 2017-2032 (USD Million)
TABLE 307. BRICS Metabolomics Reagents Market Size, by LC-MS, 2017-2032 (USD Million)
TABLE 308. BRICS Metabolomics Reagents Market Size, by NMR, 2017-2032 (USD Million)
TABLE 309. BRICS Metabolomics Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 310. BRICS Metabolomics Reagents Market Size, by Chromatography Columns, 2017-2032 (USD Million)
TABLE 311. BRICS Metabolomics Reagents Market Size, by Derivatization Reagents, 2017-2032 (USD Million)
TABLE 312. BRICS Metabolomics Reagents Market Size, by Ionization Reagents, 2017-2032 (USD Million)
TABLE 313. BRICS Metabolomics Reagents Market Size, by Solvents, 2017-2032 (USD Million)
TABLE 314. BRICS Metabolomics Reagents Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 315. BRICS Metabolomics Reagents Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 316. BRICS Metabolomics Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 317. BRICS Metabolomics Reagents Market Size, by Agriculture Food Safety, 2017-2032 (USD Million)
TABLE 318. BRICS Metabolomics Reagents Market Size, by Biomarker Discovery, 2017-2032 (USD Million)
TABLE 319. BRICS Metabolomics Reagents Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 320. BRICS Metabolomics Reagents Market Size, by Drug Development, 2017-2032 (USD Million)
TABLE 321. BRICS Metabolomics Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 322. G7 Metabolomics Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 323. G7 Metabolomics Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 324. G7 Metabolomics Reagents Market Size, by GC-MS, 2017-2032 (USD Million)
TABLE 325. G7 Metabolomics Reagents Market Size, by LC-MS, 2017-2032 (USD Million)
TABLE 326. G7 Metabolomics Reagents Market Size, by NMR, 2017-2032 (USD Million)
TABLE 327. G7 Metabolomics Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 328. G7 Metabolomics Reagents Market Size, by Chromatography Columns, 2017-2032 (USD Million)
TABLE 329. G7 Metabolomics Reagents Market Size, by Derivatization Reagents, 2017-2032 (USD Million)
TABLE 330. G7 Metabolomics Reagents Market Size, by Ionization Reagents, 2017-2032 (USD Million)
TABLE 331. G7 Metabolomics Reagents Market Size, by Solvents, 2017-2032 (USD Million)
TABLE 332. G7 Metabolomics Reagents Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 333. G7 Metabolomics Reagents Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 334. G7 Metabolomics Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 335. G7 Metabolomics Reagents Market Size, by Agriculture Food Safety, 2017-2032 (USD Million)
TABLE 336. G7 Metabolomics Reagents Market Size, by Biomarker Discovery, 2017-2032 (USD Million)
TABLE 337. G7 Metabolomics Reagents Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 338. G7 Metabolomics Reagents Market Size, by Drug Development, 2017-2032 (USD Million)
TABLE 339. G7 Metabolomics Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 340. NATO Metabolomics Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 341. NATO Metabolomics Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 342. NATO Metabolomics Reagents Market Size, by GC-MS, 2017-2032 (USD Million)
TABLE 343. NATO Metabolomics Reagents Market Size, by LC-MS, 2017-2032 (USD Million)
TABLE 344. NATO Metabolomics Reagents Market Size, by NMR, 2017-2032 (USD Million)
TABLE 345. NATO Metabolomics Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 346. NATO Metabolomics Reagents Market Size, by Chromatography Columns, 2017-2032 (USD Million)
TABLE 347. NATO Metabolomics Reagents Market Size, by Derivatization Reagents, 2017-2032 (USD Million)
TABLE 348. NATO Metabolomics Reagents Market Size, by Ionization Reagents, 2017-2032 (USD Million)
TABLE 349. NATO Metabolomics Reagents Market Size, by Solvents, 2017-2032 (USD Million)
TABLE 350. NATO Metabolomics Reagents Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 351. NATO Metabolomics Reagents Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 352. NATO Metabolomics Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 353. NATO Metabolomics Reagents Market Size, by Agriculture Food Safety, 2017-2032 (USD Million)
TABLE 354. NATO Metabolomics Reagents Market Size, by Biomarker Discovery, 2017-2032 (USD Million)
TABLE 355. NATO Metabolomics Reagents Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 356. NATO Metabolomics Reagents Market Size, by Drug Development, 2017-2032 (USD Million)
TABLE 357. NATO Metabolomics Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 358. Global Metabolomics Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 359. United States Metabolomics Reagents Market Size, 2017-2032 (USD Million)
TABLE 360. United States Metabolomics Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 361. United States Metabolomics Reagents Market Size, by GC-MS, 2017-2032 (USD Million)
TABLE 362. United States Metabolomics Reagents Market Size, by LC-MS, 2017-2032 (USD Million)
TABLE

Companies Mentioned

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biocrates Life Sciences AG
  • Bruker Corporation
  • Danaher Corporation
  • Merck KGaA
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.
  • Waters Corporation

Related Topics

Related Reports

Metabolomics Mixes & Kits Market - Global Forecast 2026-2032 - Product Image

Metabolomics Mixes & Kits Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Untargeted Metabolomics Market - Global Forecast 2026-2032 - Product Image

Untargeted Metabolomics Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Metabolomics Reagent Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Metabolomics Reagent Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 185 Pages
  • Global
From
Metabolomics Market Report 2026 - Product Image

Metabolomics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Metabolomics Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2026-2035) - Product Image

Metabolomics Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2026-2035)

  • Report
  • 350 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.